Halozyme Therapeutics
HALO
#2129
Rank
S$12.16 B
Marketcap
S$102.59
Share price
3.17%
Change (1 day)
48.52%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of March 2026 : S$3.45 Billion

According to Halozyme Therapeutics's latest financial reports the company's total assets are S$3.45 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$3.24 B15.6%
2024-12-31S$2.80 B22.53%
2023-12-31S$2.28 B-7.27%
2022-12-31S$2.46 B65.34%
2021-12-31S$1.49 B94.61%
2020-12-31S$0.76 B0.56%
2019-12-31S$0.76 B26.84%
2018-12-31S$0.60 B-13.51%
2017-12-31S$0.69 B83.74%
2016-12-31S$0.37 B47.19%
2015-12-31S$0.25 B17.25%
2014-12-31S$0.21 B70.05%
2013-12-31S$0.12 B-21.72%
2012-12-31S$0.16 B93.47%
2011-12-31S$85.16 M-27.62%
2010-12-31S$0.11 B8.64%
2009-12-31S$0.10 B-1.08%
2008-12-31S$0.10 B-26.46%
2007-12-31S$0.14 B110.65%
2006-12-31S$70.67 M106.96%
2005-12-31S$34.14 M27.61%
2004-12-31S$26.76 M2333.54%
2003-12-31S$1.09 M174.86%
2002-12-31S$0.4 M727.21%
2001-12-31S$0.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
S$259.41 B 7,416.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$268.09 B 7,668.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$150.53 B 4,261.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$191.34 B 5,444.09%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
S$25.62 B 642.54%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$0.96 B-72.15%๐Ÿ‡บ๐Ÿ‡ธ USA